Tools

Support

Start Your Investment Journey With UsOPEN ACCOUNT

Accretion Pharmaceuticals Ltd.

ACCPL

Accretion Pharmaceuticals Ltd.

ACCPL

Accretion Pharmaceuticals Ltd. Share Price

199.55 0.00 (0.00%)

Overview Financials Technicals Events News

Accretion Pharmaceuticals is engaged in the business of manufacturing and marketing of Tablets, Capsules, Oral Liquid, External Preparations (Ointment, Cream, Gel, Lotion, Medicated Shampoo, Mouthwash, Dusting Powder), And Oral Powder (Sachet, Dry Syrup) etc. Apart from manufacturing products for direct sales, our Company also manufactures various pharmaceutical products for different marketers on loan license or contract manufacturing basis. Our business is majorly carried out on principal-to-principal basis with different marketers. As on the date of this Red Herring Prospectus, we cater to multiple corporate clients on loan licence and/or contract manufacturing basis.

199.55Today's Low

200.00Today's High

53.8052W Low

214.7052W High

Fundamentals

Market Cap ₹222Cr	EPS ₹9.02
Book Value/Share ₹14.87	P/E Ratio (TTM) 22.94
Industry P/E (TTM) 45.66	P/B Ratio 14.58
Long Term D/E 0.22	ROE 27.62%
Dividend Yield (TTM) 0.00%

Analysis

Overview

Key stock indicators that show how well a company is doing, making it easier to understand its true value and performance.

Strong Outperformer

Below Average Quality

High Price Fluctuation

Disclosure and Disclaimer

Shareholding Pattern

Shareholding pattern shows how a company’s shares (ownership) are distributed among different shareholding entities like promoters, Foreign Institutional Investors (FIIs), Domestic Institutional Investors (DIIs), and retail investors, among others. Changes in the shareholding pattern can indicate the performance outlook of a stock.

FAQs on Accretion Pharmaceuticals Ltd.

The share price of Accretion Pharmaceuticals Ltd. is ₹199.55 on NSE as of 28/8/2026, 12:47:20 pm. Share prices may change frequently due to market movements.

The market capitalisation of Accretion Pharmaceuticals Ltd. is ₹222Cr as of 28/8/2026, 12:47:20 pm

The current Price to Earnings (P/E) ratio of Accretion Pharmaceuticals Ltd. is 22.95 as of 28/8/2026, 12:47:20 pm

The Price to Book (P/B) ratio of Accretion Pharmaceuticals Ltd. stands at 14.58 as of 28/8/2026, 12:47:20 pm

Accretion Pharmaceuticals Ltd. reported an ROE of 27.62% for the last reported financial year on a consolidated account basis.

As of 28/8/2026, 12:47:20 pm, Accretion Pharmaceuticals Ltd.’s shareholding pattern is: promoters hold 73.50%, FIIs hold 0.00%, DIIs hold 2.80%, and public shareholders hold 23.70%.

The 52-week high of Accretion Pharmaceuticals Ltd. is ₹200.00 and the 52-week low is ₹199.55 as of 28/8/2026, 12:47:20 pm.

The earnings per share (EPS) of Accretion Pharmaceuticals Ltd. is ₹3.39 for the quarter ended Dec 2024.

The stock symbol of Accretion Pharmaceuticals Ltd. is ACCPL.

You can buy Accretion Pharmaceuticals Ltd. shares by opening a demat and trading account with Share.Market and placing a buy order on NSE or BSE during market hours.

The fair value of Accretion Pharmaceuticals Ltd. depends on factors such as earnings growth, financial performance, and overall market conditions. Investors should assess fundamentals before making investment decisions.

Income Statement

Also called a profit and loss statement, an income statement shows a company’s income, expenses, and how much profit or loss it has made over a specific accounting period. It provides a clear view of how well the business is running.

Particulars (in Cr)	Dec 2024	Q/Q Change
Operating Revenue	17.10	-
Other Income	0.07	-
Total Income	17.17	-
Total Expenditure	12.70	-
EBIDT	4.47	-
Depreciation	0.21	-
Interest	0.37	-
Tax	1.12	-
Net Profit	2.77	-

Balance Sheet

A balance sheet is a financial statement that details a company’s assets, liabilities, and shareholders’ equity at a given time. It helps assess how financially strong and stable the company is.

Particulars (in Cr)	Mar 2026
Total Current Assets	60.40
Total Non-Current Assets	16.29
Fixed assets	13.41
Total Assets	76.68
Total Current liabilities	20.84
Total Non Current Liabilities	1.13
Total Equity Plus Liabilities	76.68
Total Shareholder Funds	54.71
Total Debt to Equity	23.00%

Cash Flow

Cash flow highlights the cash or cash equivalents moving in and out of a company during a particular period. It provides a clear picture of how well a company manages its cash by tracking its operating, investing and financing activities.

Particulars (in Cr)	Mar 2026
Cash from Operating Activity	-14.53
Cash from Financing Activities	27.04
Cash from Investing Activities	-8.53
Net Cash Flow	3.97

Time Period: Daily

SMA/EMA (Moving Average) Analysis

Bullish Moving Averages16

Bearish Moving Averages0

5 Day

198.90

10 Day

199.40

20 Day

190.70

30 Day

182.10

50 Day

171.50

100 Day

141.50

150 Day

116.80

200 Day

108.00

Indicators

RSI (14)

61.01

MACD (12, 26)

9.32

MACD Signal Line (9)

9.87

MFI (14)

67.28

ATR (14)

8.08

ADX (14)

37.76

ROC (21)

20.94

ROC (125)

191.31

Pivot Analysis

Pivot analysis uses a special price point, called the pivot point, to show the overall market trend during different periods. This pivot point is the average of the previous day’s high, low, and closing prices of a specific asset.

Type	R1	R2	R3	PP	S1	S2	S3
Classic	199.85	200.15	200.30	199.70	199.40	199.25	198.95

Note: Support and Resistance level for the day, calculated based on price range of the previous trading day.

Volume Analysis

Volume analysis tracks how many shares were traded for a specific period. Total traded volume represents the overall number of shares traded, while combined delivery volume indicates only those shares which are delivered (transferred for ownership). Delivered shares indicate long-term investor interest.

199.55Today's Low

200.00Today's High

53.8052W Low

214.7052W High

Fundamentals

Market Cap ₹222Cr	EPS ₹9.02
Book Value/Share ₹14.87	P/E Ratio (TTM) 22.94
Industry P/E (TTM) 45.66	P/B Ratio 14.58
Long Term D/E 0.22	ROE 27.62%
Dividend Yield (TTM) 0.00%